Alvotech and Teva have received FDA clearance for their product SIMLANDI® (adalimumab-ryvk), a novel substitutable biosimilar to Humira®.

Donepezil, a small molecule, acts as an acetylcholinesterase inhibitor, preventing the breakdown of the neurotransmitter acetylcholine in the brain, thus helping improve cognition.

Encoded Therapeutics Receives UK Regulatory Nod for Experimental Gene Treatment ETX101 Aimed at Dravet Syndrome.

Phenylephrine, a small drug molecule, acts as an alpha-1 adrenergic receptor agonist to help dilate the pupil for eye exams and surgeries.

Oscotec/Adel has commenced the initial human administration phase of their Phase 1 trial, testing the anti-tau antibody ADEL-Y01 as a potential treatment for Alzheimer's.

TAR-210 is an intravesical drug delivery system that is designed to provide local, continuous release of erdafitinib.

Immunofoco Reveals U.S. and China Regulators Grant Green Light to IND Submissions for Novel EpCAM CAR-T Therapy Aimed at Treating Severe Solid Cancers.

Metoclopramide, marketed under the brand name REGLAN®, is a small molecule drug that acts as a dopamine-2 (D2) antagonist.

OncoC4 Reveals Initial Participant with Late-Stage Prostate Cancer Receives Dose in Early to Mid-Stage Study for BNT316/ONC-392, a Collaborative Effort with BioNTech.

Hutchmed and Inmagene have exercised licensing options for two drug candidates, IMG-007 and IMG-004, as per their strategic collaboration agreement.

Absci Begins Preclinical Studies on ABS-101, a New Leading Candidate for an Anti-TL1A Antibody, Created and Enhanced with Advanced AI Design Tools.

Mupirocin, also known by its brand name CENTANY®, is a small molecule drug that works as an RNA synthetase inhibitor to treat bacterial infections.